World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
53
Citations
8773
World Ranking
4001
National Ranking
166

Emma Di Carlo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Emma Di Carlo sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 115 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Emma Di Carlo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Emma Di Carlo sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Emma Di Carlo is affiliated with the University of Chieti-Pescara in Italy. Their research spans multiple intersecting fields primarily focused on medicine, biochemistry, genetics, molecular biology, and immunology. Their publication record highlights a particular emphasis on oncology, molecular biology, immunology, pulmonary and respiratory medicine, and cancer research.

The scientist's work covers a range of topics that include:

  • Cytokine Signaling Pathways and Interactions
  • Immune Cell Function and Interaction
  • CRISPR and Genetic Engineering
  • Cancer Immunotherapy and Biomarkers
  • Chemokine receptors and signaling
  • Immunotherapy and Immune Responses
  • Cytomegalovirus and herpesvirus research

Frequent coauthors in their collaborative projects include:

  • Carlo Sorrentino
  • Stefania L. Ciummo
  • Cristiano Fieni
  • Luigi D'Antonio
  • Paola Lanuti

The publication venues associated with their work show continuity in cancer-related and immunological research with repeat contributions to:

  • Journal of Experimental & Clinical Cancer Research
  • Journal for ImmunoTherapy of Cancer
  • Translational Lung Cancer Research
  • Frontiers in Immunology
  • Antioxidants

Recent papers authored or coauthored by Emma Di Carlo include:

  • Oxidative Stress and Age-Related Tumors, 2024, published in Antioxidants
  • State of the art CRISPR-based strategies for cancer diagnostics and treatment, 2024, published in Biomarker Research

Other relevant publications featuring their collaborators are:

  • Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival, 2021, Frontiers in Immunology
  • The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs, 2021, Frontiers in Cell and Developmental Biology
  • Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway, 2022, Journal of Experimental & Clinical Cancer Research

Best Publications

  • The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

    Emma Di Carlo;Guido Forni;PierLuigi Lollini;Mario P. Colombo

  • DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice

    Stefania Rovero;Augusto Amici;Emma Di Carlo;Roberto Bei

  • Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

    Katia Boggio;Giordano Nicoletti;Emma Di Carlo;Federica Cavallo

  • CXCL1/Macrophage Inflammatory Protein-2-Induced Angiogenesis In Vivo Is Mediated by Neutrophil-Derived Vascular Endothelial Growth Factor-A

    Patrizia Scapini;Monica Morini;Cristina Tecchio;Simona Minghelli

  • Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

    Patrizia Nanni;Giordano Nicoletti;Carla De Giovanni;Lorena Landuzzi

  • NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.

    Paolo Carrega;Fabrizio Loiacono;Emma Di Carlo;Angelo Scaramuccia

  • CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph.

    Paolo Carrega;Irene Bonaccorsi;Emma Di Carlo;Barbara Morandi

  • IL-21 Induces Tumor Rejection by Specific CTL and IFN-γ-Dependent CXC Chemokines in Syngeneic Mice

    Emma Di Carlo;Alberto Comes;Anna Maria Orengo;Ombretta Rosso

  • Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

    Elena Quaglino;Manuela Iezzi;Cristina Mastini;Augusto Amici

  • Immune Events Associated with the Cure of Established Tumors and Spontaneous Metastases by Local and Systemic Interleukin 12

    Federica Cavallo;Emma Di Carlo;Monia Butera;Roberta Verrua

  • Coexpression of IL‐6 and soluble IL‐6R causes nodular regenerative hyperplasia and adenomas of the liver

    Domenico Maione;Emma Di Carlo;Wei Li;Piero Musiani

  • IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease

    Paola Bossù;Detlef Neumann;Elda Del Giudice;Antonio Ciaramella

  • Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes.

    Mirella Giovarelli;Paola Cappello;Guido Forni;Theodora Salcedo

  • Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy.

    Irma Airoldi;Emma Di Carlo;Claudia Cocco;Carlo Sorrentino

  • Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

    Claudia Curcio;Emma Di Carlo;Raphael Clynes;Mark J. Smyth

  • Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis

    Tonino Alonzi;Ian P. Newton;Paul J. Bryce;Emma Di Carlo

  • Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice

    Pasquale Buanne;Emma Di Carlo;Lorenzo Caputi;Laura Brandolini

  • Expression of IL-32 in Human Lung Cancer Is Related to the Histotype and Metastatic Phenotype

    Carlo Sorrentino;Emma Di Carlo

  • CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine.

    Alberto Comes;Ombretta Rosso;Anna Maria Orengo;Emma Di Carlo

  • Interleukin-27 Acts as Multifunctional Antitumor Agent in Multiple Myeloma

    Claudia Cocco;Nicola Giuliani;Emma Di Carlo;Emanuela Ognio

Frequent Co-Authors

Piero Musiani
Piero Musiani University of Chieti-Pescara
Guido Forni
Guido Forni University of Turin
Mario P. Colombo
Mario P. Colombo Fondazione IRCCS Istituto Nazionale dei Tumori
Patrizia Nanni
Patrizia Nanni University of Bologna
Vito Pistoia
Vito Pistoia Boston Children's Hospital
Silvano Ferrini
Silvano Ferrini University of Genoa
Federica Cavallo
Federica Cavallo University of Turin
Domenico Ribatti
Domenico Ribatti University of Bari Aldo Moro
Mirella Giovarelli
Mirella Giovarelli University of Turin
Andrea Modesti
Andrea Modesti University of Rome Tor Vergata

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens the door to various healthcare and research careers. For those interested in clinical roles, transitioning into nursing is a common pathway. Many students explore online rn programs for non nurses in florida, which offer flexible options for individuals with science backgrounds wanting to enter nursing without traditional prerequisites.

If you are looking for quicker routes into nursing, consider accelerated nursing programs near me. These programs are designed to fast-track degree completion for students who already hold a bachelor's degree in another field, like Immunology.

For those starting their nursing careers or seeking foundational credentials, lpn schools easy to get into provide accessible options to enter practical nursing. These programs often serve as stepping stones to more advanced nursing roles.

Advanced practice roles, such as becoming a nurse practitioner, also align well with an Immunology background. Exploring the easiest nurse practitioner program options can help you identify accelerated or less competitive programs to advance your career efficiently.

Best Scientists Citing Emma Di Carlo

Trending Scientists

Recently Published Articles